Oncoustics
Toronto, CA · 1 known investors
Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers. The company operates research collaborations with Stanford University, University of Toronto, and international health institutes across Toronto, Cairo, and Palo Alto.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Founders & leadership
AE
Ahmed El KaffasFounder
BR
Beth RogozinskiCEO
Investors · 1
In the news
- Oncoustics - Activation Capitalactivation.capital · 2025
- Oncoustics Raises $5M for AI-Driven Point-of-Care Diagnosticshitconsultant.net · 2022
- Oncoustics Closes $5M+ Seed Fundingfinsmes.com · 2022
- Oncoustics Inc.osler.com · 2022
- Oncoustics Closes New Funding to Advance its AI Innovations in Ultrasound and Address Huge Unmet Clinical Needs in Liver Diseasefinance.yahoo.com · 2022
- Oncoustics secures $5.5 million CAD to help spot liver disease using AI | BetaKitbetakit.com · 2022